Michael RodenFollow1 paperOpenAlex ↗PapersJournal of HepatologyReview·29 SepEASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy
Journal of HepatologyReview·29 SepEASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy